Key takeaways:
Immunotherapy is a type of cancer treatment that uses your own immune system to fight cancer.
Most immunotherapy side effects come from inflammation caused by an exaggerated immune system response.
Depending on the severity, immunotherapy side effects can be managed with supportive care, antihistamines, and/or immunosuppressants. In some cases, you may need to stop taking your medication altogether.
Understandably, a cancer diagnosis can be quite daunting. But in today’s era of modern medicine, new treatment options are beginning to change what it actually means to live with cancer. New cancer medications — or new uses for cancer medications — seem to be approved every month.
Immunotherapy is one large group of cancer medications. It first popped up in the 1980s, and it’s grown to include a variety of treatments that use your immune system to fight cancer. Many people look to this type of treatment to avoid side effects that are common with chemotherapy and radiation. And although immunotherapies have a number of upsides, these unique medications are not without their own concerns.
Read on to find out more about specific side effects related to immunotherapy.
Immunotherapy is a cancer treatment that uses your own immune system to fight cancer cells. There are many types of immunotherapy medications.
In general, T cells are an important part of most immunotherapy treatments. They’re a type of white blood cell in your immune system. They help direct your immune response and attack cancer cells.
There are several different types of immunotherapy. These are discussed more below.
Your immune system has built-in checkpoints, or switches. They exist to make sure that your immune system is focused on fighting foreign invaders, not healthy cells. But tumor cells are sneaky. They can keep these switches “off” so they can hide from your immune system.
Immune checkpoint inhibitor medications prevent cancer cells from turning off these switches. This allows T cells to be “on” so they can find and kill cancer cells.
Examples include ipilimumab (Yervoy), pembrolizumab (Keytruda), and nivolumab (Opdivo).
T-cell transfer therapy takes T cells from your body and they’re changed in one of two ways:
Your T cells can be trained to better recognize your cancer. This is known as chimeric antigen receptor (CAR) T-cell therapy.
Your most efficient T cells can be selected and grown in large amounts. However, this option is currently only available in clinical trials.
In both scenarios, modified T cells are infused back into your body as a form of treatment.
Monoclonal antibodies are proteins that are created in a lab that recognize specific targets on cancer cells. Once they find cancer cells in your body, they recruit cells from your immune system to destroy them.
Examples include rituximab (Rituxan) and blinatumomab (Blincyto).
Cancer vaccines are different from vaccines used to prevent illness. Cancer vaccines help your immune system better recognize and destroy cancer cells.
Available cancer vaccines include sipuleucel-T (Provenge) and talimogene laherparepvec (Imlygic).
Immune system modulators are medications that stimulate or suppress your immune system to fight cancer cells.
Many of these medications are available, but examples include lenalidomide (Revlimid), pomalidomide (Pomalyst), and imiquimod (Aldara, Zyclara).
Many immunotherapy side effects occur due to an exaggerated reaction from your immune system. The immune system can overshoot its target and affect healthy cells and cancer cells. This results in inflammation that causes side effects.
These side effects vary based on your medication, its dose, and the type and stage of your cancer. However, there are some side effects that all immunotherapies have in common:
Flu-like symptoms, such as fever, chills, and body aches
Fatigue
Swelling
Irregular heartbeat
Stuffy nose
Diarrhea
Infection
Organ inflammation
Here, we'll discuss some more specific side effects based on the type of immunotherapy.
The most common side effects of immune checkpoint inhibitors include:
Skin side effects, such as itching and rash
Fatigue
Colon inflammation
Lung inflammation
Liver inflammation
Low or high thyroid function
Muscle/joint aches
The most common side effects from CAR T-cell therapy are related to a condition called cytokine release syndrome (CRS). Cytokines are proteins that help your immune system communicate. But they can also cause inflammation as part of their response. Symptoms of CRS can range from mild to severe and include:
Fever
Chills
Nausea
Rash
Headache
Other possible side effects of CAR T-cell therapy include:
Neurologic toxicities: This includes symptoms like dizziness, shaking, and confusion.
Low blood counts: These include your white blood cells, red blood cells, and platelets. This can occur for weeks to months after your treatment and can raise your risk for infection.
Low number of B cells/hypogammaglobulinemia: B cells are a type of white blood cell that make antibodies in response to a foreign invader. Low number of B cells and hypogammaglobulinemia can raise your risk for infection. Hypogammaglobulinemia means you have low levels of antibodies in your body.
Medications like lenalidomide, pomalidomide, and thalidomide can cause many side effects — several which are mentioned above. But they can also cause blood clots, nerve pain, and serious birth defects. Your care team will also recommend that you take a blood thinner, such as aspirin or warfarin, to lower risk of blood clots.
Imiquimod is a cream, and it commonly causes skin reactions.
Hair loss or thinning is not a commonly reported side effect of immunotherapy. However, it’s linked to some medications. It’s rare and happens in about 1% to 2% of people receiving immune checkpoint inhibitors. It has also been reported rarely with brexucabtagene autoleucel (Tecartus) and thalidomide (Thalomid).
Immunotherapy can also be associated with more severe side effects.
If inflammation in a certain part of your body is severe enough, you may need to stop using your medication. This risk is highest if you’re receiving two different immune checkpoint inhibitors at the same time.
Your care team may give you corticosteroids (“steroids”) at home or in the hospital to help control inflammation.
While most people experience mild-to-moderate CRS, it can be life-threatening. Damage to various organs can occur if CRS isn’t treated appropriately. Serious side effects of CRS include:
Low blood pressure
Low oxygen levels
Abnormal heartbeat
Poor kidney function
Trouble breathing
Capillary leak syndrome, where fluids can leak from blood vessels and cause low blood pressure and organ damage
Macrophage activation syndrome and hemophagocytic lymphohistiocytosis, which are severe inflammatory conditions that cause widespread inflammation and organ damage
Similarly, most neurotoxicities are mild and reversible if treated appropriately. But severe reactions — such as seizures and brain swelling — can also occur.
Your care team will need to closely monitor you for at least 2 to 4 weeks after your infusion. You should also avoid driving or doing tasks that require intense concentration for at least 8 weeks.
Imlygic is a cancer vaccine. It’s made from a weakened form of the herpes virus. It may put you at a higher risk for cold sores or eye infections. Provenge is another cancer vaccine, and it may cause side effects like blood clots, blood vessel problems, and intense infusion reactions.
Cytokines and interleukins can cause many serious side effects that are similar to CRS.
Immunotherapy works differently than chemotherapy, so expected side effects will be different.
In many cases, people may think that immunotherapy is better tolerated than chemotherapy. For example, a recent study found that immune checkpoint inhibitors are less likely to cause severe side effects than chemotherapy.
However, this isn’t always the case. Both chemotherapy and immunotherapy can cause severe side effects.
The most important thing you can do is tell your care team about any side effects you’re experiencing. Many of these side effects can be managed with supportive care, especially if they’re treated early.
For example, rash and itching caused by immune checkpoint inhibitors can be treated with topical steroids and antihistamines, such as diphenhydramine (Benadryl). In other cases, medications like oral steroids or other immunosuppressants may be needed to throw ice on your immune system.
Immunotherapy is an exciting cancer treatment that uses your own immune system to fight cancer. It has different side effects than more traditional cancer treatments. Most immunotherapy treatments cause mild flu-like symptoms, however more serious reactions can happen. They’re unique to the type of immunotherapy.
BioVex, Inc. (2022). Imlygic [package insert]. Amgen, Inc.
Celgene Corporation. (2021). Thalomid [package insert].
Crayne, C. B., et al. (2019). The immunology of macrophage activation syndrome. Frontiers in Immunology.
Eno, J. (2017). Immunotherapy through the years. Journal of the Advanced Practitioner in Oncology.
Food and Drug Administration. (2022). Oncology (cancer) / hematologic malignancies approval notifications.
Huq, M., et al. (2021). Hypogammaglobulinemia. StatPearls.
Johns Hopkins Medicine. (n.d.). Hemophagocytic lymphohistiocytosis.
Kennedy, L. B., et al. (2020). A review of cancer immunotherapy toxicity. CA: A Cancer Journal for Clinicians.
Kite Pharma, Inc. (2021). Tecartus [package insert].
Locke, F. L. (2022). Solid tumor TIL therapy is infiltrating multiple centers with lympho-”sights” set on becoming standard of care. The Hematologist.
Magee, D. E., et al. (2020). Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: A systematic review and meta-analysis of randomized clinical trials. Annals of Oncology.
National Cancer Institute. (n.d.). B cell.
National Cancer Institute. (n.d.). Capillary leak syndrome.
National Cancer Institute. (n.d.). Cytokine.
National Cancer Institute. (n.d.). Cytokine release syndrome.
National Cancer Institute. (n.d.). Immune system modulator.
National Cancer Institute. (n.d.). T cell.
National Cancer Institute. (2019). Cancer treatment vaccines.
National Cancer Institute. (2019). Immunotherapy side effects.
National Cancer Institute. (2019). Immunotherapy to treat cancer.
National Cancer Institute. (2019). Monoclonal antibodies.
National Cancer Institute. (2022). Immune checkpoint inhibitors.
National Cancer Institute. (2022). T-cell transfer therapy.
National Comprehensive Cancer Network. (2020). Immunotherapy side effects: CAR T-cell therapy. NCCN Guidelines for Patients.
Pagel, J. M., et al. (2017). Chimeric antigen receptor (CAR) T-cell therapy. JAMA Oncology.
Zarbo, A., et al. (2017). Immune-related alopecia (areata and universalis-type) in cancer patients receiving immune checkpoint inhibitors. British Journal of Dermatology.